From a technical perspective applying RT-qPCR for resolving the status of ERBB2, ESR1, PGR, and MKI67 represents an efficient and reproducible alternative for decentralized routine assessment of breast cancer molecular subtypes. The gene discussed is ERBB2; the disease is breast cancer.